Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study)

Epidemiology Registry Working Group

doi:10.1136/annrheumdis-2021-eular.2216

Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study)

Epidemiology Registry Working Group

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	256-257
Number of pages	3
Journal	Annals of the rheumatic diseases
Volume	80
DOIs	https://doi.org/10.1136/annrheumdis-2021-eular.2216
Publication status	Published - Jun 2021

Access to Document

10.1136/annrheumdis-2021-eular.2216

Cite this

@article{2b1d3df503eb4e43909e3b76d175b4d3,

title = "Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study)",

author = "{Epidemiology Registry Working Group} and K Lauper and D Mongin and SA Bergstra and D Choquette and C Codreanu and {De Cock}, D and L Dreyer and O Elkayam and K Hyrich and F Iannone and N Inanc and E Kristianslund and TK Kvien and B Leeb and G Lukina and D Nordstr{\"o}m and K Pavelka and M Pombo-Suarez and Z Rotar and MJ Santos and A Strangfeld and D Courvoisier and A Finckh",

year = "2021",

month = jun,

doi = "10.1136/annrheumdis-2021-eular.2216",

language = "English",

volume = "80",

pages = "256--257",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ ",

}

Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study). / Epidemiology Registry Working Group.
In: Annals of the rheumatic diseases, Vol. 80, 06.2021, p. 256-257.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study)

AU - Epidemiology Registry Working Group

AU - Lauper, K

AU - Mongin, D

AU - Bergstra, SA

AU - Choquette, D

AU - Codreanu, C

AU - De Cock, D

AU - Dreyer, L

AU - Elkayam, O

AU - Hyrich, K

AU - Iannone, F

AU - Inanc, N

AU - Kristianslund, E

AU - Kvien, TK

AU - Leeb, B

AU - Lukina, G

AU - Nordström, D

AU - Pavelka, K

AU - Pombo-Suarez, M

AU - Rotar, Z

AU - Santos, MJ

AU - Strangfeld, A

AU - Courvoisier, D

AU - Finckh, A

PY - 2021/6

Y1 - 2021/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000692629300406&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1136/annrheumdis-2021-eular.2216

DO - 10.1136/annrheumdis-2021-eular.2216

M3 - Meeting Abstract

SN - 0003-4967

VL - 80

SP - 256

EP - 257

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -

Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study)

Access to Document

Other files and links

Cite this